BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33338698)

  • 1. Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study.
    Panholzer B; Bajorat T; Haneya A; Kowalski D; Juhl D; Rocke A; Shneyder M; Kuta P; Clausnizer H; Junker R; Kowalski A; Tulun A; Al-Suraimi A; Cremer J; Kalbhenn J; Zieger B; Nowak-Göttl U
    Blood Cells Mol Dis; 2021 Mar; 87():102526. PubMed ID: 33338698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
    Hayakawa M; Takano K; Kayashima M; Kasahara K; Fukushima H; Matsumoto M
    J Atheroscler Thromb; 2021 Apr; 28(4):396-401. PubMed ID: 33116032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.
    Kalbhenn J; Schlagenhauf A; Rosenfelder S; Schmutz A; Zieger B
    J Heart Lung Transplant; 2018 Aug; 37(8):985-991. PubMed ID: 29650295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb ischemia and bleeding in patients requiring venoarterial extracorporeal membrane oxygenation.
    Son AY; Khanh LN; Joung HS; Guerra A; Karim AS; McGregor R; Pawale A; Pham DT; Ho KJ
    J Vasc Surg; 2021 Feb; 73(2):593-600. PubMed ID: 32623105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.
    Kalbhenn J; Schmidt R; Nakamura L; Schelling J; Rosenfelder S; Zieger B
    J Atheroscler Thromb; 2015; 22(3):265-71. PubMed ID: 25186021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation.
    Mazzeffi M; Bathula A; Tabatabai A; Menaker J; Kaczorowski D; Madathil R; Galvagno S; Pasrija C; Rector R; Tanaka K; Herr D
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):882-887. PubMed ID: 32758410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation.
    Tamura T; Horiuchi H; Obayashi Y; Fuki M; Imanaka M; Kuroda M; Nishimura S; Amano M; Sakamoto J; Tamaki Y; Enomoto S; Miyake M; Kondo H; Izumi C; Nakagawa Y
    Cardiovasc Interv Ther; 2019 Oct; 34(4):358-363. PubMed ID: 30656612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study.
    Aubron C; Cheng AC; Pilcher D; Leong T; Magrin G; Cooper DJ; Scheinkestel C; Pellegrino V
    Crit Care; 2013 Apr; 17(2):R73. PubMed ID: 23594433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy.
    Kalbhenn J; Wittau N; Schmutz A; Zieger B; Schmidt R
    Perfusion; 2015 Nov; 30(8):675-82. PubMed ID: 25823366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature.
    Malfertheiner MV; Pimenta LP; Bahr VV; Millar JE; Obonyo NG; Suen JY; Pellegrino V; Fraser JF
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):45-52. PubMed ID: 29084501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes.
    Ius F; Sommer W; Tudorache I; Avsar M; Siemeni T; Salman J; Puntigam J; Optenhoefel J; Greer M; Welte T; Wiesner O; Haverich A; Hoeper M; Kuehn C; Warnecke G
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):761-7. PubMed ID: 25736272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support).
    Schlagenhauf A; Kalbhenn J; Geisen U; Beyersdorf F; Zieger B
    Hamostaseologie; 2020 Jun; 40(2):221-225. PubMed ID: 32455462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up.
    Beurtheret S; Mastroianni C; Pozzi M; D'Alessandro C; Luyt CE; Combes A; Pavie A; Leprince P
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):691-5. PubMed ID: 22228837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational study.
    Büchsel M; Geisen U; Beckenkamp C; Wengenmayer T; Zieger B; Westermann D; Siegel PM
    Thromb J; 2023 Jan; 21(1):4. PubMed ID: 36627675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal membrane oxygenation in severe trauma patients with bleeding shock.
    Arlt M; Philipp A; Voelkel S; Rupprecht L; Mueller T; Hilker M; Graf BM; Schmid C
    Resuscitation; 2010 Jul; 81(7):804-9. PubMed ID: 20378236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding during veno-venous ECMO cannot reliably be predicted by rotational thrombelastometry (ROTEM™).
    Hellmann C; Schmutz A; Kalbhenn J
    Perfusion; 2018 May; 33(4):289-296. PubMed ID: 29188749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults.
    Napp LC; Kühn C; Hoeper MM; Vogel-Claussen J; Haverich A; Schäfer A; Bauersachs J
    Clin Res Cardiol; 2016 Apr; 105(4):283-96. PubMed ID: 26608160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.